Microbiome and MS

Multiple sclerosis (MS) is the most common chronic inflammatory disease of the central nervous system which is characterized by inflammatory demyelination and neurodegeneration. Here is the latest research on the influence of the human microbiome on this dymyelinating disorder.

April 3, 2020
Review
Open Access

Nutrition, IBD and Gut Microbiota: A Review

Nutrients
Maria Chiara MentellaGiacinto Abele Donato Miggiano
December 6, 2019
Review
Open Access

You've got male: Sex and the microbiota-gut-brain axis across the lifespan

Frontiers in Neuroendocrinology
Minal JaggarJohn F Cryan
April 4, 2020
Open Access

Microbiome varies between multiple sclerosis subtypes

Nature Reviews. Neurology
Ian Fyfe
March 8, 2020
Open Access

Perturbation of gut microbiota decreases susceptibility but does not modulate ongoing autoimmune neurological disease

Journal of Neuroinflammation
Clemens GödelGurumoorthy Krishnamoorthy
June 17, 2020
Open Access

Epstein Barr virus-immortalized B lymphocytes exacerbate experimental autoimmune encephalomyelitis in xenograft mice

Journal of Medical Virology
Pascal PolepoleLuwen Zhang
September 6, 2019
Review

Bifidobacteria: A probable missing puzzle piece in the pathogenesis of multiple sclerosis

Multiple Sclerosis and Related Disorders
Mehdi ToghiSoudeh Ghafouri-Fard
March 6, 2020
Open Access

Host and Microbial Tryptophan Metabolic Profiling in Multiple Sclerosis

Frontiers in Immunology
Lorenzo GaetaniTeresa Zelante
November 11, 2019
Open Access

Gut microbiome of treatment-naïve MS patients of different ethnicities early in disease course

Scientific Reports
R E VenturaM J Blaser
April 22, 2020
Comment / Editorial

The future of microbiome research in neuroinflammatory disorders

Multiple Sclerosis and Related Disorders
Emmanuelle WaubantHelen Tremlett
April 9, 2020
Review
Open Access

Fecal Microbiota Transplantation in Neurological Disorders

Frontiers in Cellular and Infection Microbiology
Karuna E W VendrikMaria Fiorella Contarino
August 24, 2019
Review

Inhibitory milieu at the multiple sclerosis lesion site and the challenges for remyelination

Glia
Dylan A GallowayRashmi Kothary
October 19, 2019
Open Access

Normal gut microbiome in NMDA receptor encephalitis

Neurology. Neuroimmunology and Neuroinflammation
Julia HerkenHarald Prüss
February 11, 2020
Review
Open Access

Relationships Between Vitamin D, Gut Microbiome, and Systemic Autoimmunity

Frontiers in Immunology
Erin A Yamamoto, Trine N Jørgensen
April 15, 2020

Deep DNA metagenomic sequencing reveals oral microbiome divergence between monozygotic twins discordant for multiple sclerosis severity

Journal of Neuroimmunology
Anne I BoullerneDouglas L Feinstein
April 17, 2020
Review
Open Access

Microbiome in Multiple Sclerosis; Where Are We, What We Know and Do Not Know

Brain Sciences
Marina Kleopatra BozikiNikolaos Grigoriadis
March 13, 2020
Open Access

Gut microbiome variation is associated to Multiple Sclerosis phenotypic subtypes

Annals of Clinical and Translational Neurology
Tatjana ReyndersJeroen Raes
November 23, 2019
Review

The gut microbiome in neurological disorders

Lancet Neurology
John F CryanTimothy G Dinan
July 1, 2020
Open Access

Rapid improvement in Alzheimer's disease symptoms following fecal microbiota transplantation: a case report

The Journal of International Medical Research
Sabine Hazan

Sign up to follow this feed and discover related papers.

Related Feeds

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

Acute Disseminated Encephalomyelitis

Acute disseminated encephalomyelitis (ADEM) is a rare inflammatory demyelinating disease of the central nervous system. Discover the latest research on acute disseminated encephalomyelitis here.

© 2020 Meta ULC. All rights reserved
/feed-previews/microbiome-and-ms/300264ee-2362-4185-98b9-a2ca266c176a